Gout and hyperuricemia

American Family Physician

Volumn 59, Issue 4, 1999, Pages 925-934

  Harris, Mark D ^a   Siegel, Lori B ^b   Alloway, Jeffrey A ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; COLCHICINE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DIETARY INTAKE; GOUT; HUMAN; METATARSAL BONE; SYNOVIAL FLUID LEVEL; UREMIA;

ACUTE DISEASE; ALGORITHMS; FEMALE; GOUT; HUMANS; MALE; SEX DISTRIBUTION; UNITED STATES; URIC ACID;

EID: 0344197566     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990;16:539-50.
2. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
3. Mikkelson WH, Dodge HJ, Valkenberg H. The distribution of plasma uric acid values in a population unselected as to gout and hyperuricemia. Am J Med 1965;39:242-51.
4. O'Sullivan JB. Gout in a New England town: a prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972;31:166-9.
5. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972;15:189-92.
6. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
7. Kelley W, Schumacher HR. Crystal-associated synovitis. Gout. In: Kelley WN, ed. Textbook of rheumatology. 4th ed. Philadelphia: Saunders, 1993:1291-336.
8. Grahame R, Scott JT. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461-8.
9. Puig JG, Michan AD, Jimenez ML, Perez de Ayala C, Mateos FA, Capitan CF, et al. Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 1991;151:726-32.
10. Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 1973;16:431-45.
11. Kozin F, McCarty DJ. Rheumatoid factors in the serum of gouty patients [Letter]. Arthritis Rheum 1977;20:1559-60.
12. Macfarlane DG, Dieppe PA. Diuretic-induced gout in elderly women. Br J Rheumatol 1985;24:155-7.
13. Hench PS. The diagnosis of gout and gouty arthritis. J Lab Clin Med 1936;220:48.
14. Nakayama DA, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL. Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum 1984;27:468-71.
15. Wolfe F, Cathey MA. The misdiagnosis of gout and hyperuricemia. J Rheumatol 1991;18:1232-4.
16. Bomalaski JS, Schumacher HR. Podagra is more than gout. Bull Rheum Dis 1984;34:1-8.
17. Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 1988;14:441-57.
18. Agudelo CA. Gout and hyperuricemia. Curr Opin Rheumatol 1989;1:286-93.
19. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflamatory drugs. N Engl J Med 1992;327:749-54.
20. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflamatory drugs and the risk for chronic renal disease. Ann Intern Med 1991;115:165-72.
21. Dieppe PA. Investigation and management of gout in the young and the elderly. Ann Rheum Dis 1991;50:263-6.
22. Wallace SL, Singer JZ. Review: systemic toxicity associated with intravenous administration of colchicine - guidelines for use. J Rheumatol 1988; 15:495-9.
23. Axelrod D, Preston S. Comparison of parenteral adrenocorticotrophic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988;31:803-5.
24. Mikadashi JA, Hochberg MC, Moy EM. White B, Handwerger BS. Single-dose parenteral ACTH in the treatment of acute gouty arthritis: a high benefit to toxicity ratio. Arthritis Rheum 1994;37: S428, 1593.
25. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotrophic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994;21:1325-7.
26. Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 1993;20:111-3.
27. Cohen A. Gout. Am J Med Sci 1936;192:448-93.
28. Medellin M, Erckson A, Enzenauer R. Variability of treatment for gouty arthritis between rheumatologists and primary care physicians. J Clin Rheumatol 1997;3:24-7.
29. Bellamy N, Gilbert JR, Brooks PM, Emerson BT, Campbell J. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. J Rheumatol 1988;15:1841-7.
30. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects Am Intern Med 1961;55:179.
31. Kelly W, Wortmann RL. Crystal-associated synovitis. Gout and hyperuricemia. In: Kelly WN, ed. Textbook of rheumatology. 4th ed. Philadelphia: Saunders, 1993:1340-51.
32. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993;27: 337-43.
33. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984;76:47-56.